Abortion care (QS199)
This quality standard covers care for women of any age (including girls and young women under 18) who request an abortion. It describes high-quality care in priority areas for improvement.
Search results
2067 results
-
-
Abortion care
Everything NICE has said on abortion care in an interactive flowchart.
-
Venous thromboembolism in adults: diagnosis and management (QS29)
This quality standard covers diagnosing and treating venous thromboembolism (VTE) in adults. VTE includes deep vein thrombosis (DVT) and pulmonary embolism. It describes high-quality care in priority areas for improvement.
-
What is the effectiveness and safety of extended pharmacological VTE prophylaxis for patients who have been discharged after treatment for COVID-19 pneumonia?
Recommendation ID NG186/2 Question What is the effectiveness and safety of extended pharmacological VTE prophylaxis for patients who have
-
In women with type 1 diabetes who are already pregnant, what is the most effective method of glucose monitoring to improve maternal and baby outcomes: continuous glucose monitoring flash glucose monitoring?
Recommendation ID NG3/7 Question In women with type 1 diabetes who are already pregnant, what is the most effective method of glucose monitoring
-
In women with type 1 diabetes who are planning to become pregnant, what is the most effective method of glucose monitoring to improve maternal and baby outcomes: continuous glucose monitoring flash glucose monitoring intermittent capillary blood glucose monitoring?
Recommendation ID NG3/6 Question In women with type 1 diabetes who are planning to become pregnant, what is the most effective method of
-
What is the most clinically and cost-effective tool for diagnosing peripheral arterial disease in people with diabetes?
Recommendation ID CG147/6 Question What is the most clinically and cost-effective tool for diagnosing peripheral arterial disease in people
-
What is the most clinically and cost-effective tool for establishing the severity of peripheral arterial disease and the impact on mortality, morbidity and limb amputation in people with diabetes?
Recommendation ID CG147/7 Question What is the most clinically and cost-effective tool for establishing the severity of peripheral arterial
-
In children and young people with diabetic ketoacidosis, what is the most effective resuscitation fluid (0.9% sodium chloride vs PlasmaLyte 148) for managing DKA?
Recommendation ID NG18/6 Question In children and young people with diabetic ketoacidosis, what is the most effective resuscitation fluid
-
What are the most clinically effective interventions (including social prescribing and structured community support) for managing post‑COVID‑19 syndrome? Does effectiveness vary for different population groups (for example sex, age, socioeconomic group, black, Asian and minority ethnic group communities or people with learning disabilities)? Do any symptoms of post‑COVID‑19 syndrome predict the need for specialist intervention? Are there clusters of symptoms that identify response to interventions in post‑COVID‑19 syndrome? What is the clinical effectiveness of different service models of multimodality/multidisciplinary post‑COVID‑19 syndrome rehabilitation in improving patient‑reported outcomes (such as quality of life)? What is the clinical effectiveness of exercise interventions for people with post‑COVID‑19 syndrome? Does effectiveness vary for different population groups (for example sex, age, socioeconomic group, black, Asian and minority ethnic group communities or people with learning disabilities)? Does early exercise rehabilitation assist in improving symptoms of post‑COVID‑19 syndrome?
Recommendation ID NG188/2 Question What are the most clinically effective interventions (including social prescribing and structured community
-
What is the most clinically and cost-effective dual antiplatelet therapy for people aged 75 and over with an acute coronary syndrome, who are having percutaneous coronary intervention (PCI)?
Recommendation ID NG185/1 Question What is the most clinically and cost-effective dual antiplatelet therapy for people aged 75 and over
-
Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. This could be in the form of randomised controlled trials or published registry data. Find out what only in research means on the NICE interventional procedures guidance page .
Recommendation ID IPG683/1 Question Evidence on the safety and efficacy of balloon cryoablation for squamous dysplasia of the oesophagus
-
Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate in quantity and quality. Therefore, this procedure should only be used in the context of research. This could be in the form of randomised controlled trials or published registry data. Find out what only in research means on the NICE interventional procedures guidance page .
Recommendation ID IPG682/1 Question Evidence on the safety and efficacy of balloon cryoablation for Barrett's oesophagus is inadequate
-
What is the clinical and cost effectiveness of opioids for the management of acute sciatica?
Recommendation ID NG59/8 Question What is the clinical and cost effectiveness of opioids for the management of acute sciatica?
-
Evidence on the safety of the swallowable gastric balloon capsule for weight loss shows infrequent but potentially serious adverse events: For people who need to lose weight in the short term for medical reasons, the evidence of efficacy is adequate to support the use of this procedure provided that special arrangements are in place for clinical governance, consent and audit. Find out what special arrangements mean on the NICE interventional procedures guidance page . For people who are aiming for long-term weight loss, the evidence on efficacy is inadequate in quantity and quality, so the procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page .
Recommendation ID IPG684/1 Question Evidence on the safety of the swallowable gastric balloon capsule for weight loss shows infrequent
-
What symptoms do children, young people, pregnant women and older people with suspected post‑COVID‑19 syndrome present with?
Recommendation ID NG188/5 Question What symptoms do children, young people, pregnant women and older people with suspected post‑COVID‑19
-
Evidence on the safety of pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis shows that this procedure can cause serious but well-recognised side effects. Evidence on its efficacy is inadequate in quality. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE website .
Recommendation ID IPG681/1 Question Evidence on the safety of pressurised intraperitoneal aerosol chemotherapy for peritoneal carcinomatosis
-
What is the prevalence and incidence of post-COVID-19 syndrome? Does it differ from the prevalence and incidence across different population groups (for example in black, Asian and minority ethnic group communities)?
Recommendation ID NG188/3 Question What is the prevalence and incidence of post-COVID-19 syndrome? Does it differ from the prevalence and
-
Develop and validate new and existing screening tools (including physical, psychological and psychiatric aspects) for post-COVID-19 syndrome in a UK population. What tools are validated for screening for post‑COVID‑19 syndrome, which are the most accurate at identifying post‑COVID‑19 syndrome in a UK population and what is their effectiveness in guiding management?
Recommendation ID NG188/7 Question Develop and validate new and existing screening tools (including physical, psychological and
-
What is the effectiveness and safety of standard-dose compared with intermediate‑dose pharmacological VTE prophylaxis for patients with COVID-19 pneumonia, with or without additional risk factors for VTE?
Recommendation ID NG186/1 Question What is the effectiveness and safety of standard-dose compared with intermediate‑dose pharmacological
-
What is the clinical effectiveness of D-dimer and other blood tests and clinical features as prognostic markers of developing post‑COVID‑19 syndrome?
Recommendation ID NG188/4 Question What is the clinical effectiveness of D-dimer and other blood tests and clinical features as prognostic
-
What factors, including identifiable clusters of symptoms, influence: the risk of developing post-COVID-19 syndrome the trajectory of post-COVID-19 syndrome?
Recommendation ID NG188/1 Question What factors, including identifiable clusters of symptoms, influence: the risk of developing
-
What is the natural history of post-COVID-19 syndrome?
Recommendation ID NG188/6 Question What is the natural history of post-COVID-19 syndrome? Any explanatory notes(if applicable)
-
Venous thromboembolism
Everything NICE has said on assessing, diagnosing, treating and reducing the risk of venous thromboembolism in adults in an interactive flowchart
-
Neurological conditions
Everything NICE has said on neurological conditions in an interactive flowchart
-
Suspected neurological conditions: recognition and referral (QS198)
This quality standard covers assessing and referring children (under 16) and adults (16 and over) who have symptoms or signs associated with neurological conditions. It describes high-quality care in priority areas for improvement.
-
Colorectal cancer
Everything NICE has said on diagnosing and managing colorectal (bowel) cancer in an interactive flowchart
-
Lower urinary tract symptoms in men
Everything NICE has said on managing lower urinary tract symptoms in men in an interactive flowchart
-
Intrapartum care for women with obstetric complications
Everything NICE has said on intrapartum care for women with obstetric complications in an interactive flowchart
-
Early and locally advanced breast cancer
Everything NICE has said on diagnosing and treating early and locally advanced breast cancer in an interactive flowchart
-
Rheumatoid arthritis
Everything NICE has said on managing rheumatoid arthritis in adults in an interactive flowchart
-
Mental health problems in people with learning disabilities
Mental health problems in people with learning disabilities
-
Vitamin D: supplement use in specific population groups
Everything NICE has said on preventing vitamin D deficiency in specific population groups in an interactive flowchart
-
Acutely ill patients in hospital
Everything NICE has said on recognising and responding to acute illness in adults in hospital in an interactive flowchart
-
Urinary incontinence in neurological disease
Everything NICE has said on managing lower urinary tract dysfunction resulting from neurological disease and injury in an interactive flowchart
-
Urogenital conditions
Everything NICE has said on urogenital conditions in an interactive flowchart
-
Diabetes in children and young people
Everything NICE has said on diagnosing and managing type 1 and 2 diabetes in children and young people in an interactive flowchart
-
Type 1 diabetes in adults
Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart
-
Diabetes in pregnancy
Everything NICE has said on managing diabetes and its complications before, during and after pregnancy in an interactive flowchart
-
Type 2 diabetes in adults
Everything NICE has said on managing type 2 diabetes in adults in an interactive flowchart
-
Blood and immune system conditions
Everything NICE has said on blood and immune system conditions in an interactive flowchart
-
Liver cancers
Everything NICE has said on liver and bile duct cancers in an interactive flowchart
-
Pancreatitis
Everything NICE has said on pancreatitis in an interactive flowchart
-
Eating disorders
Everything NICE has said on identifying and managing eating disorders in people 8 years and over in an interactive flowchart
-
Osteoarthritis
Everything NICE has said on the care and management of osteoarthritis in adults in an interactive flowchart
-
Low back pain and sciatica
Everything NICE has said on low back pain and sciatica in an interactive flowchart
-
Lower limb peripheral arterial disease
Everything NICE has said on diagnosing and managing lower limb peripheral arterial disease in an interactive flowchart
-
Obesity
Everything NICE has said on preventing, identifying, assessing and managing obesity in an interactive flowchart
-
Blood and bone marrow cancers
Everything NICE has said on blood and bone marrow cancers including leukaemia in an interactive flowchart
-
Parkinson's disease
Everything NICE has said on diagnosing and managing Parkinson's disease in adults in primary and secondary care in an interactive flowchart